Procter & Gamble
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Procter & Gamble
Public Company Edition: CARGO Therapeutics grossed $281.3m, giving it the fifth-largest biopharma IPO this year. Also, Alkermes completed its cancer business spinout as Mural Oncology, which launched with $275m, and Xencor sold Ultomiris and Monjuvi royalties for $215m.
National Advertising Division recommends Oral Essentials discontinue claims on packaging that Lumineux strips are "first on the market that are delicious and clinically proven to whiten teeth as well as the leading brand, without the harm associated with bleaches.”
There may be a trend towards spinning off business units but Merck continues to sees its three-pillar structure as providing the best protection from downturns in any individual segment.
Contribution of price increases to P&G’s organic sales growth will decrease 3 to 4 points during its FY2024 while volume will “progress sequentially,” says CFO Andre Schulten during firm’s first-quarter earnings briefing. Net sales up 6% to $21.9bn in July-September.
- OTC, Consumer
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.